MENU
NERV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Minerva Neurosciences (NERV) Earnings Date & Reports

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

NERV is expected to report earnings to rise 91.07% to -107 cents per share on May 13

Minerva Neurosciences NERV Stock Earnings Reports
Q1'25
Est.
$-1.07
Q4'24
Missed
by $1.53
Q3'24
Beat
by $3.98
Q2'24
Missed
by $0.12
Q1'24
Missed
by $0.12
The last earnings report on February 25 showed earnings per share of -56 cents, missing the estimate of 97 cents. With 3.11K shares outstanding, the current market capitalization sits at 11.26M.
View a ticker or compare two or three
NERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1500 District Avenue
Phone
+1 617 600-7373
Employees
9
Web
https://www.minervaneurosciences.com